Physiologically-relevant, serum-free in vitro angiogenesis platform
AssigneeSouth Dakota Board of Regents
InventorsLaura A.E. Brunmaier, Travis W. Walker, Cyle Miller, Timothy M. Brenza
Life of this patent
Estimating the term…
Loading patent…
AssigneeSouth Dakota Board of Regents
InventorsLaura A.E. Brunmaier, Travis W. Walker, Cyle Miller, Timothy M. Brenza
Estimating the term…
A custom platform is developed that is capable of culturing endothelial cells three-dimensionally while inducing physiological stimuli on the cells. A model includes serum-free conditions, allowing more quantifiable angiogenesis studies that investigate the dose dependent effects of various growth factors. Angiogenesis plays a critical role during development, wound healing, and disease; therefore, further investigation of the pathway has broad implications. Also, the development of in vitro vascularized tissue models via angiogenesis provides the ability to investigate endothelial responses after exposure to nanoparticles and mechanisms of drug delivery.
A physiologically-relevant, serum-free in vitro angiogenesis platform, comprising:
A system for a physiologically-relevant, serum-free in vitro angiogenesis platform, comprising:
A method for physiologically-relevant, serum-free in vitro angiogenesis, comprising:
Dependencies are inferred from the claim text.